-

Owens & Minor Announces Major Innovations to Products & Healthcare Services Network

Transformative investments in technology, automation and analytics capabilities will help improve supply chain visibility and resiliency for Products & Healthcare Services customers and lay the foundation for future innovations

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced important milestones in advancing the medical distribution capabilities of its Products & Healthcare Services (P&HS) business segment, which provides essential products and services to thousands of healthcare customers. These milestones are the result of recent company investments in new technology, automation and analytics capabilities geared specifically toward driving greater efficiencies for the P&HS segment and improving the customer experience. Initial roll out will focus on two new Owens & Minor distribution centers in West Virginia and South Dakota.

Transformative investments in technology, automation and analytics capabilities will help improve supply chain visibility and resiliency for Products & Healthcare Services customers

Share

“Over the past two years, our P&HS teammates have worked creatively and diligently to identify areas where technology investments, operational upgrades and new approaches to how we do business could have a meaningful impact for our customers,” said Andy Long, EVP and CEO, Products & Healthcare Services, Owens & Minor. “We’re excited for these advancements to go live in West Virginia and South Dakota and look forward to the benefits they will provide for other Owens & Minor customers in years to come.”

These new capabilities will be operational at two new Owens & Minor sites starting in 2025:

  • A new state of the art distribution center with advanced automation and robotics technology to help streamline and expedite inventory management and order fulfilment in West Virginia (now open)
  • A second state of the art distribution center in South Dakota that will integrate the latest augmented reality (AR) system for supporting the order picking process (opening spring 2025)

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home.

For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram®, and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™.

For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.

OMI-IR

OMI-CORP

Contacts

Media contact

Stacy Law
mediarelations@owens-minor.com

Industry:

Owens & Minor, Inc.

NYSE:ACH
Details
Headquarters: Richmond, VA
CEO: Edward Pesicka
Employees: 6000
Organization: PUB
Release Versions
English

Contacts

Media contact

Stacy Law
mediarelations@owens-minor.com

Social Media Profiles
Owens & Minor
Owens & Minor
Owens & Minor
More News From Owens & Minor, Inc.

Accendra Health Reports Third Quarter 2026 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the third quarter ended September 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Over the several weeks since I started, a number of themes have become clear to me. We have strong brands, favorable end markets, and a teammate popula...

Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it executed an amendment to its Receivables Purchase Agreement (the “Receivables Sale Program”) on October 29, 2026. The amendment, among other things, extends the Scheduled Termination Date of the facility to October 2029, and the $150 million size of the Receivables Sale Program is unchanged. “We are pleased to have worked with our banking partner to extend the Receivables Sale Program until...

Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard​

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 27, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with Section 802.01B of the NYSE’s continued listing standards that the Company have an average market capitalization of not less than $50.0 million over a consecutive 30 trading-day period and stockholders’ equity of not less than $50.0 millio...
Back to Newsroom